Pallardy M - Search Results

1

Consensus on the Key Characteristics of Immunotoxic Agents as a Basis for Hazard Identification.

Germolec DR, Lebrec H, Anderson SE, Burleson GR, Cardenas A, Corsini E, Elmore SE, Kaplan BLF, Lawrence BP, Lehmann GM, Maier CC, McHale CM, Myers LP, Pallardy M, Rooney AA, Zeise L, Zhang L, Smith MT. Germolec DR, et al. Among authors: pallardy m. Environ Health Perspect. 2022 Oct;130(10):105001. doi: 10.1289/EHP10800. Epub 2022 Oct 6. Environ Health Perspect. 2022. PMID: 36201310 Free PMC article.

2

Testing strategies in immunotoxicology.

Pallardy M, Kerdine S, Lebrec H. Pallardy M, et al. Toxicol Lett. 1998 Dec 28;102-103:257-60. doi: 10.1016/s0378-4274(98)00315-4. Toxicol Lett. 1998. PMID: 10022262 Review.

3

Tools to investigate and avoid drug-hypersensitivity in drug development.

Corsini E, Casula M, Tragni E, Galbiati V, Pallardy M. Corsini E, et al. Among authors: pallardy m. Expert Opin Drug Discov. 2018 May;13(5):425-433. doi: 10.1080/17460441.2018.1437141. Epub 2018 Feb 6. Expert Opin Drug Discov. 2018. PMID: 29405076 Review.

4

In vitro evaluation of drug-induced toxic effects on the immune system as assessed by proliferative assays and cytokine production.

Pallardy M, Lebrec H, Blot C, Burleson GR, Bohuon C. Pallardy M, et al. Eur Cytokine Netw. 1991 May-Jun;2(3):201-6. Eur Cytokine Netw. 1991. PMID: 1893072 No abstract available.

5

Immunotoxicological investigation using pharmaceutical drugs. In vitro evaluation of immune effects using rodent or human immune cells.

Lebrec H, Roger R, Blot C, Burleson GR, Bohuon C, Pallardy M. Lebrec H, et al. Among authors: pallardy m. Toxicology. 1995 Feb 6;96(2):147-56. doi: 10.1016/0300-483x(94)02956-u. Toxicology. 1995. PMID: 7886685

6

Assessment of apoptosis in xenobiotic-induced immunotoxicity.

Pallardy M, Biola A, Lebrec H, Bréard J. Pallardy M, et al. Methods. 1999 Sep;19(1):36-47. doi: 10.1006/meth.1999.0825. Methods. 1999. PMID: 10525436 Review.

7

Immune modification due to chemical interference with transmembrane signalling: application to polycyclic aromatic hydrocarbons.

Pallardy M, Mishal Z, Lebrec H, Bohuon C. Pallardy M, et al. Int J Immunopharmacol. 1992 Apr;14(3):377-82. doi: 10.1016/0192-0561(92)90167-j. Int J Immunopharmacol. 1992. PMID: 1319963 Review.

8

Quantitation of cytokine mRNA expression as an endpoint for prediction and diagnosis of xenobiotic-induced hypersensitivity reactions.

Gaspard I, Kerdine S, Pallardy M, Lebrec H. Gaspard I, et al. Among authors: pallardy m. Methods. 1999 Sep;19(1):64-70. doi: 10.1006/meth.1999.0828. Methods. 1999. PMID: 10525439

9

Th(1)/Th(2) responses to drugs.

Lebrec H, Kerdine S, Gaspard I, Pallardy M. Lebrec H, et al. Among authors: pallardy m. Toxicology. 2001 Feb 2;158(1-2):25-9. doi: 10.1016/s0300-483x(00)00398-x. Toxicology. 2001. PMID: 11164989 Review.

10

Interleukin-4 plays a dominant role in Th1- or Th2-like responses during the primary immune response to the hapten penicillin.

Kerdine S, Lebrec H, Bertoglio J, Pallardy M. Kerdine S, et al. Among authors: pallardy m. Mol Immunol. 1996 Jan;33(1):71-7. doi: 10.1016/0161-5890(95)00119-0. Mol Immunol. 1996. PMID: 8604226

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

182 results

Search Page